Influence of dibornol-HES on electrophysiological parameters in the period of restoration of blood flow in rabbit myocardium
https://doi.org/10.20538/1682-0363-2018-4-6-15
Abstract
Objective. Dibornol-HES, a water-soluble drug based on the derivative of 2,6-diisobornyl-4-methylphenol Dibornol conjugated with hydroxyethyl starch, can reduce the occurrence and severity of arrhythmias by preventive intravenous administration, but it is unknown whether the drug could reduce the myocardial arrhythmogenicity once ischemia has developed at the developed ischemia.
Materials and methods. In the model of acute ischemia / reperfusion of the rabbit heart, the effect of Dibornol-HEC (80 mg/kg body weight of the animal) on the electrophysiological indices characterizing myocardial arrhythmogenicity (global and border dispersion of repolarization) was studied during the restoration of blood flow. In the model of acute ischemia / reperfusion with 64 unipolar epicardial leads, the activation-recovery intervals were measured and global and border dispersion of repolarization in the native rabbits (control group, n = 9) and in the rabbits treated by Dibornol-HES (on the 25th minute of occlusion, the experimental group, n = 6).
Results. The introduction of Dibornol-HES did not lead to a change in the electrocardiographic parameters of rabbits. By the 30th minute of the coronary occlusion on the ECG in the animals of the control and the experimental groups, the intervals RR, QT, QTc were shortened (p < 0.05). In the animals of both groups by the 30th minute of coronary occlusion, the global dispersion of repolarization increased (p < 0.05), the boundary dispersion of repolarization also increased (p < 0.05), due to the decrease in the duration of the activation-recovery intervals in the ischemic zone (p < 0.05). During the 30-minute reperfusion the magnitude of the global dispersion of repolarization did not change in animals of the both groups, and the magnitude of the border dispersion of repolarization in the control rabbits decreased (p < 0.05), while in the rabbits treated by Dibornol-HES the border dispersion of repolarization did not changed.
Conclusion. In rabbits of the experimental group, the values of the global and border dispersions of repolarization did not differ from those of the animals in the control group. Therefore, the administration to Dibornol-HES just prior to reperfusion does not lead to the decrease in the dispersion of repolarization increased as a result of acute ischemic myocardial damage.
About the Authors
M. A. VaykshnorayteRussian Federation
Vaykshnorayte Marina A., PhD
50, Pervomayskaya Str., Syktyvkar, 167892, Komi Republic
V. A. Vityazev
Russian Federation
Vityazev Vladimir A., PhD
50, Pervomayskaya Str., Syktyvkar, 167892, Komi Republic
N. A. Vahnina
Russian Federation
Vahnina Nadezda A., PhD
50, Pervomayskaya Str., Syktyvkar, 167892, Komi Republic
V. D. Shadrina
Russian Federation
Shadrina Vera D., PhD
50, Pervomayskaya Str., Syktyvkar, 167892, Komi Republic
M. A. Torlopov
Russian Federation
Torlopov Mikhail A., PhD
48, Pervomayskaya Str., Syktyvkar, 167892, Komi Republic
I. Y. Chukicheva
Russian Federation
Chukicheva Irina Ju., DChSc
48, Pervomayskaya Str., Syktyvkar, 167892, Komi Republic
A. V. Kuchin
Russian Federation
Kuchin Alexander V., DChSc, Corresponding Member of RAS
48, Pervomayskaya Str., Syktyvkar, 167892, Komi Republic
References
1. Jeong E.M., Liu M., Sturdy M., Gao G., Varghese S.T., Sovari A.A. Metabolic stress, reactive oxygen species, and arrhythmia. J. Mol. Cell. Cardiol. 2012; 52 (2): 454–463. DOI: 10.1016/j.yjmcc.2011.09.018.
2. Оpie L.H. Reperfusion injury and its pharmacological modification. Circ. 1989; 80 (4): 1049–1061. DOI: 10.1161/01.CIR.80.4.1049.
3. Abuja P.M., Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistant of lipoproteins. Clin. Chim. Acta. 2001; 306 (1–2): 1–17. DOI: 10.1016/S0009-8981(01)00393-X.
4. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc. Drugs Ther. 1991; 5 (2): 249–268. DOI: 10.1007/BF00054747.
5. Han J., Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circ. Res. 1964; 14: 44–60. DOI: 10.1161/01.RES.14.1.44.
6. Salama G., Kanai A.J., Huang D., Efimov I.R., Girouard S.D., Rosenbaum D.S. Hypoxia and hypothermia enhance spatial heterogeneities of repolarization in guinea pig hearts: analysis of spatial autocorrelation of optically recorded action potential durations. J. Cardiovasc. Electrophysiol. 1998; 9 (2): 164–183. DOI: 10.1111/j.1540-8167.1998.tb00897.x.
7. Sedova K.A., Bernikova O.G., Azarov J.I., Shmakov D.N., Vityazev V.A., Kharin S.N. Effects of echinochrome on ventricular repolarization in acute ischemia. Journal of Electrocardiology. 2015; 48 (2): 181–186. DOI: 10.1016/j.jelectrocard.2015.01.003.
8. Plotnikov M.B., Ivanov I.S., Smol’jakova V.I. Antioxidant activity of o-isobornylphenol derivative in cerebral ischemia in rats. Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii – Questions of Biological, Medical and Pharmaceutical Chemistry. 2010; 8 (5): 23–25 (in Russ.)
9. Logvinov S.V., Plotnikov M.B., Zhdankina A.A., Chernysheva G.A., Smol’yakova V.I., Ivanov I.S., Kuchin A.V., Chukicheva I.Yu., Varakuta E. Yu. Structural Changes in the Choroidoretinal Complex of the Eye in Total Transient Cerebral Ischemia and Their Correction. Neuroscience and Behavioral Physiology. 2012; 42 (9): 1019–1023. DOI: 10.1007/s11055-012-9672-1.
10. Smolyakova V.I., Shhetinin P.P., Plotnikova T.M., Kuchin A.V. Endothelium-protective activity of Dibornol under the conditions of the model of myocardial ischemia/reperfusion. Medicinskie nauki. Fundamental’nye issledovanija – Medical Sciences. Fundamental Research. 2014; 7: 790–794 (in Russ.)
11. Plotnikova T.M., Chernysheva G.A., Smolyakova V.I., Shchetinin P.P., Kuchin A.V., Chukicheva I.Yu., Plotnikov M.B. Hemorheological effects of diborol in the model of myocardial ischemia / reperfusion. Bulletin of Experimental Biology and Medicine. 2014; 157 (2): 173–176 (in Russ.) DOI: 10.1007/s10517-014-2527-8.
12. Plotnikova T., Plotnikov M., Chernysheva G., Smol’yakova V., Shchetinin P., Kuchin A., Chukicheva I. The antiarrhythmic effect of 4-methyl-2,6-diisobornylphenol in myocardial ischemia/reperfusion. Key Engineering Materials. 2016; 683: 469–474. DOI: 10.4028/www.scientific.net/kem.683.469.
13. Vlasov P.S., Sergeyeva O.Yu., Domnina N.S., Chukicheva I.Yu., Buravlyov E.V., Kuchin A.V. Macromolecular antioxidants based on polysaccharides and derivatives of 2,6-diisobornyl -4-methylphenol. Himiya prirodnyh soedinenij – Chemistry of Natural Compounds. 2012; 4: 481–484 (in Russ.)
14. Shatalov D.O., Kedik S.A., Panov A.V., Ajdakova A.V., Sisitkina O.E., Birjulin S.I., Torlopov M.A., Buravlev E.V., Chukicheva I.Ju., Kuchin A.V. Development of a medicinal product for the treatment and prevention of cardiovascular diseases. Abstracts of the X All-Russian Conference “Chemistry and Medicine” with the Youth Scientific School (June 1–6, 2015): 2015: 210–212 (in Russ.)
15. Plotnikov M.B., Aliev O.A., Sidekhmenova A.V., Kuchin A.V., Chukicheva I.Yu., Torlopov M.A., Buravlyov E.V. Means that improve the rheological properties of blood. Patent of the Russian Federation 10.04.2015. Bul. № 10 (in Russ.)
16. Plotnikov M.B., Ivanov I.S., Smolyakova V.I., Chernysheva G.A., Kuchin A.V., Chukicheva I.Yu., Krasnov E.A. Antioxidant activity of the derivative of O-Isobornylphenol with cerebral ischemia in rats. Voprosy biologicheskoy, meditsinskoy i farmatsevticheskoy khimii – Questions of Biological, Medical and Pharmaceutical Chemistry. 2010; 8 (5): 23–25 (in Russ.)
17. Shhetinin P.P. Effect of antioxidant therapy on the survival of rats in conditions of simulated acute myocardial ischemia/reperfusion. Aktual’nye problemy gumanitarnyh i estestvennyh nauk – Actual problems of the Нumanities and Natural Sciences. 2015; 7: 153–156 (in Russ.)
18. Chernysheva G.A., Smol’jakova V.I., Plotnikov M.B., Janovskaja E.A., Gurto R.V., Udut V.V., Kuchin A.V., Chukicheva I.Ju. The pharmacokinetics of the phenolic antioxidant 4-methyl-2,6-diisobornylphenol in intravenous administration. Jeksperimental’naja i klinicheskaja farmakologija – Experimental and Clinical Pharmacology. 2011; 74 (9): 20–22 (in Russ.)
19. Opthof T., Coronel R., Wilms-Schopman F.J., Plotnikov A.N., Shlapakova I.N., Danilo P.Jr., Rosen M.R., Janse M.J. Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion. Heart Rhythm. 2007; 4: 341–348. DOI: 10.1016/j.hrthm.2006.11.022.
20. Carlsson L., Abrahamsson C., Andersson B., Duker G., Schiller-Linhardt G. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarizations. Cardiovasc. Res. 1993; 27 (12): 2186–2193. DOI: 10.1093/cvr/27.12.2186.
21. Millar C.K., Kralios F.A., Lux R.L. Correlation between refractory periods and activation-recovery intervals from electrograms: effects of rate and adrenergic interventions. Circulation. 1985; 72 (6): 1372–1379.
22. Sedova K.A., Goshka S.L., Vityazev V.A., Shmakov D.N., Azarov J.E. Load-induced changes in ventricular repolarization: evidence of autonomic modulation. Can. J. Physiol. Pharmacol. 2011; Dec. 89 (12): 935–944. DOI: 10.1139/y11-098.
23. Schetinin P.P. Antiarrhythmic activity of dibornol in the conditions of the model of acute ischemia and myocardial reperfusion. Byulleten' sibirskoy meditsiny – Bulletin of Siberian Medicine. 2013; 12 (3): 153–156 (in Russ.)
24. Aiello E.A., Jabr R.I., Cole W.C. Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia. Role of oxygen radical-induced no-reflow phenomenon. Circ. Res. 1995; Jul. 77 (1): 153–162. DOI:10.1161/01.RES.77.1.153.
Review
For citations:
Vaykshnorayte M.A., Vityazev V.A., Vahnina N.A., Shadrina V.D., Torlopov M.A., Chukicheva I.Y., Kuchin A.V. Influence of dibornol-HES on electrophysiological parameters in the period of restoration of blood flow in rabbit myocardium. Bulletin of Siberian Medicine. 2018;17(4):6-15. (In Russ.) https://doi.org/10.20538/1682-0363-2018-4-6-15